Lataa...
Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity
BACKGROUND: Infants with stage 3+ retinopathy of prematurity (ROP) in zone I or zone II posterior were randomized to initial treatment with bevacizumab or laser in a multicenter trial (BEAT-ROP). The purpose of this study was to assess the effects of bevacizumab on nonophthalmologic outcomes. METHOD...
Tallennettuna:
| Julkaisussa: | J AAPOS |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826862/ https://ncbi.nlm.nih.gov/pubmed/29223789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaapos.2017.10.006 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|